The recommended management of PKC associated with TB usually consists of systemic anti-tuberculous agents and topical steroids applied to the affected eye.[2] Our patient received 12 months of systemic anti-tuberculous therapy regimen without topical treatment and responded well without complications. This evidence concerns the gene PRRT2 and tuberculosis.